Search research articles
Contact Us
Filters
Showing results (211-220 of 217) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 217 results.
Viruses
|
December 23, 2022
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
Carla S Coffin, Sarah Haylock-Jacobs, Karen Doucette, et al.
Lancet (London, England)
|
December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Edgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
CMAJ Open
|
October 24, 2019
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network
Carla S Coffin, Alnoor Ramji, Curtis L Cooper, et al.
The New England Journal of Medicine
|
November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
Man-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Nature Communications
|
January 17, 2017
Massively parallel digital transcriptional profiling of single cells
Grace X Y Zheng, Jessica M Terry, Phillip Belgrader, et al.
Nature Biotechnology
|
February 2, 2016
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing
Grace X Y Zheng, Billy T Lau, Michael Schnall-Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2022
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States
Estee Y Cramer, Evan L Ray, Velma K Lopez, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 217) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 217 results.
Viruses
|
December 23, 2022
Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
Carla S Coffin, Sarah Haylock-Jacobs, Karen Doucette, et al.
Lancet (London, England)
|
December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Edgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
CMAJ Open
|
October 24, 2019
Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network
Carla S Coffin, Alnoor Ramji, Curtis L Cooper, et al.
The New England Journal of Medicine
|
November 8, 2022
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
Man-Fung Yuen, Seng-Gee Lim, Robert Plesniak, et al.
Nature Communications
|
January 17, 2017
Massively parallel digital transcriptional profiling of single cells
Grace X Y Zheng, Jessica M Terry, Phillip Belgrader, et al.
Nature Biotechnology
|
February 2, 2016
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing
Grace X Y Zheng, Billy T Lau, Michael Schnall-Levin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2022
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States
Estee Y Cramer, Evan L Ray, Velma K Lopez, et al.
Page
of 22